| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/24/2008 | WO2008087512A1 Morpholine dopamine agonists for the treatment of pain |
| 07/24/2008 | WO2008087491A2 Method for treating or preventing symptoms of hormonal variations |
| 07/24/2008 | WO2008087461A2 Use of kynurenic acid and derivatives thereof in the treatment of conditions of the gastrointestinal tract accompanied by hypermotility and inflammation or gout or multiple sclerosis |
| 07/24/2008 | WO2008087458A2 NEW SIGMA(σ)-RECEPTOR LIGANDS WITH ANTI-APOPTOTIC AND/OR PRO-APOPTOTIC PROPERTIES OVER CELLULAR BIOCHEMICAL MECHANISMS, WITH NEUROPROTECTIVE, ANTI-CANCER, ANTI-METASTATIC AND ANTI-(CHRONIC) INFLAMMATORY ACTION |
| 07/24/2008 | WO2008087437A1 Treatment of corticoid-resistant asthma or copd with p38 map kinase inhibit (eg. sb2035809) |
| 07/24/2008 | WO2008087421A2 Male contraceptive |
| 07/24/2008 | WO2008087408A1 Modulation of proteases. particularly in the treatment of chronic ulcerous skin lesions |
| 07/24/2008 | WO2008087401A1 Sulfate salts of irbesartan and their preparation and pharmaceutical compositions |
| 07/24/2008 | WO2008087399A1 Mesylate salts of irbesartan and their preparation and pharmaceutical compositions |
| 07/24/2008 | WO2008087397A1 Tosylate salts of irbesartan and their preparation and pharmaceutical compositions |
| 07/24/2008 | WO2008087371A1 New combination for use in the treatment of inflammatory disorders |
| 07/24/2008 | WO2008087365A2 Substituted 1, 3-diphenylpropane derivatives, preparations and uses of same |
| 07/24/2008 | WO2008087278A2 5-alkyloxy-indolin-2-one derivatives, preparation thereof and application thereof in therapy as selective ligands of v2 vasopressin receptors |
| 07/24/2008 | WO2008087248A1 Levosimendan for use in treating chronic valvular disease |
| 07/24/2008 | WO2008087202A1 Triptolide derivatives for use in the treatment of acute myeloid leukemia |
| 07/24/2008 | WO2008087198A1 Pharmaceutical composition comprising a pyrazole-o-glucoside derivative |
| 07/24/2008 | WO2008087178A1 Novel 1,4- and 1,5-diarylsubstituted 1,2,3-triazoles useful as potassium channel modulators |
| 07/24/2008 | WO2008087177A1 Novel semicarbazide and carbonylhydrazide derivatives useful as potassium channel modulators |
| 07/24/2008 | WO2008087155A1 Use of entacapone in cosmetic, dermatological and pharmaceutical compositions |
| 07/24/2008 | WO2008087140A2 Liquid formulations containing a carotinoid |
| 07/24/2008 | WO2008087135A1 Iron-hydrocarbon complex compounds |
| 07/24/2008 | WO2008087123A2 Use of 5-ht6 antagonists to prevent relapse into addiction |
| 07/24/2008 | WO2008087081A1 Process for solvent removal from omeprazole salts |
| 07/24/2008 | WO2008087076A1 Pharmaceutical composition of improved stability containing taxane derivatives |
| 07/24/2008 | WO2008087030A1 Substituted pyrazoline compounds with acat inhibition activity, their preparation and use as medicaments |
| 07/24/2008 | WO2008087010A1 Use of nicotinamide for treatment and/or prevention of arteriosclerosis |
| 07/24/2008 | WO2008086949A1 Use of substituted pyranone acid derivatives for the treatment of metabolic syndrome |
| 07/24/2008 | WO2008086857A1 Triazole derivative as an hsp 90 inhibitor |
| 07/24/2008 | WO2008086854A1 5-([1,3,4] oxadiazol-2-yl)-1h-indazol and 5-([1,3,4] thiadiazol-2-yl)-1h-indazol derivatives as sgk inhibitors for the treatment of diabetes |
| 07/24/2008 | WO2008086847A2 Synthesis of chromane derivatives in the presence of ionic liquids |
| 07/24/2008 | WO2008086834A2 Pharmaceutical composition for treating incontinence |
| 07/24/2008 | WO2008086804A2 Use of i) a polyglycol and n) an active drug substance for the preparation of a pharmaceutical composition for i) mitigating the risk of alcohol induced dose dumping and/or ii) reducing the risk of drug abuse |
| 07/24/2008 | WO2008086743A1 The application of the extract of antrodia cinnamomea for inhibitting the growth of tumour cell |
| 07/24/2008 | WO2008086742A1 A medicament for improving the ovum quality and treating female infertility |
| 07/24/2008 | WO2008086739A1 Use of ursolic acid saponin, oleanolic acid saponin in preparation of increasing leucocyte and/or platelet medicine |
| 07/24/2008 | WO2008086733A1 New pharmaceutical composition |
| 07/24/2008 | WO2008086730A1 Tetrahydroquinazoline compounds and their use in preparing medicaments for treating and preventing virosis |
| 07/24/2008 | WO2008086729A1 New dihydropyrimidine compounds and their uses in manufactures of pharmaceutical medicaments for treatment and prevention against virosis |
| 07/24/2008 | WO2008086698A1 A forsythoside injection and preparation thereof |
| 07/24/2008 | WO2008086678A2 The medical use of levo-phencynonate as neuroprotective agent |
| 07/24/2008 | WO2008086612A1 Hat acetylation promoters and uses of compositions thereof in promoting immunogenicity |
| 07/24/2008 | WO2008086610A1 Hat acetylation promoters and uses of compositions thereof in promoting immunogenicity |
| 07/24/2008 | WO2008086556A1 Method of inducing an immune response |
| 07/24/2008 | WO2008073956A3 Cyclic sulfonamide derivatives and methods of their use |
| 07/24/2008 | WO2008070552A3 Inhibitors of protein tyrosine phosphatase for the promotion of physiological cardiac hypertrophy |
| 07/24/2008 | WO2008070129A3 Compositions and methods for the treatment of inflammatory disease |
| 07/24/2008 | WO2008070011A3 Combination of an hdac inhibitor and an antimetabolite |
| 07/24/2008 | WO2008070010A3 Hydroxylamine derivatives for the treatment of stroke |
| 07/24/2008 | WO2008068763A3 Mixture and method for reducing cholesterol using hydrophobic chitosan microparticles |
| 07/24/2008 | WO2008068427A3 Anti-microorganism terpenic composition |
| 07/24/2008 | WO2008068424A3 Substituted 2,5-dihydro-3h-pyrazolo[4,3-c]pyridazin-3-one derivatives, preparation thereof and use of same as cannabinoid cb1 receptor ligands |
| 07/24/2008 | WO2008068272A3 Antibacterial quinoline derivatives |
| 07/24/2008 | WO2008067781A3 A method of purification of (s)-n-methyl-3-(1-naphtyloxy)-3-(2-thienyl) propylamine hydrochloride (duloxetine) |
| 07/24/2008 | WO2008067257A3 Inhibitors of diacylglycerol o-acyltransferase type 1 enzyme |
| 07/24/2008 | WO2008066845A3 Treatment of metabolic syndrome with norfluoxetine |
| 07/24/2008 | WO2008065626A3 3-heteroaryl (amino or amido)-1- (biphenyl or phenylthiazolyl) carbonylpiperidine derivativesas orexin receptor inhibitors |
| 07/24/2008 | WO2008065068A3 Substituted dihydroimidazoles and their use in the treatment of tumors |
| 07/24/2008 | WO2008063563A3 Methods of treating keratin hyperproliferation disorders using mtor inhibitors |
| 07/24/2008 | WO2008062463A3 Improved process for the preparation of (r)-(+)-4-(ethyiamino)-3,4-dihydro-2-(3- methoxypropyl)-2h-thieno[3,2-e]-l,2-thiazine-6-sulfonamide-l,l-dioxide |
| 07/24/2008 | WO2008061754A8 Dietary or pharmaceutical compositions containing tricyclic diterpenes and derivatives thereof for the treatment of depression |
| 07/24/2008 | WO2008060934A8 Formulations of tetrahydropyridine antiplatelet agents for parenteral or oral administration |
| 07/24/2008 | WO2008060789A3 Use of spiro-oxindole compounds as therapeutic agents |
| 07/24/2008 | WO2008060764A3 Topical therapies for oral mucositis and other conditions |
| 07/24/2008 | WO2008060190A3 Ligands of 5-ht6 receptors, a pharmaceutical composition, method for the production and use thereof |
| 07/24/2008 | WO2008059370A3 Substituted bicyclocarboxyamide compounds |
| 07/24/2008 | WO2008059339A3 Isoquinoline derivatives as vanilloid receptor modulators |
| 07/24/2008 | WO2008059258A3 Imidazoles for treating multi-drug resistant bacterial infections |
| 07/24/2008 | WO2008057516A9 Oxygen delivery composition |
| 07/24/2008 | WO2008057300A9 Trpvi antagonists and uses thereof |
| 07/24/2008 | WO2008057196A3 Methods and compositions using immunomodulatory compounds for the treatment and management of spirochete and other obligate intracellular bacterial diseases |
| 07/24/2008 | WO2008056259A3 Oxazole derivatives as positive allosteric modulators of metabotropic glutamate receptors |
| 07/24/2008 | WO2008055940A8 Combination therapy with sglt-2 inhibitors and their pharmaceutical compositions |
| 07/24/2008 | WO2008055068A8 Inhibitors of histone deacetylase |
| 07/24/2008 | WO2008054690A3 Polymorphs of a hydroisoindoline tachykinin receptor antagonist |
| 07/24/2008 | WO2008053250A3 Formulations for delivery via pressurised metered dose inhalers comprising an essential oil as suspension stabiliser |
| 07/24/2008 | WO2008051808A3 Bicyclic triazoles as protein kinase modulators |
| 07/24/2008 | WO2008051599A3 Combination therapies for treating alzheimer's disease using i. a. dimebon and dolepezil |
| 07/24/2008 | WO2008049047A3 Quinoline compounds |
| 07/24/2008 | WO2008045834A3 Kinase inhibitors |
| 07/24/2008 | WO2008045686A3 Enantiomerically enriched iminopyrrolidone azirdine compositions |
| 07/24/2008 | WO2008043825A3 Pharmaceutical anti-infective composition for inhalation. |
| 07/24/2008 | WO2008042260A3 Methods of treating hyperandrogenism and conditions associated therewith by administering a fatty acid ester of an estrogen or an estrogen derivative |
| 07/24/2008 | WO2008039421A3 Pharmaceutical compositions of hdac inhibitors and chelatable metal compounds, and metal-hdac inhibitor chelate complexes |
| 07/24/2008 | WO2008038160A3 A substance with sedative effect for use in the treatment of neurotic disorders |
| 07/24/2008 | WO2008034087A3 Treating schizophrenia with combinations of levodopa and an antipsychotic agent |
| 07/24/2008 | WO2008033747A9 Multi-functional small molecules as anti-proliferative agents |
| 07/24/2008 | WO2008033308A3 Control of malignant cells proliferation through the inhibition of casein kinase 2 |
| 07/24/2008 | WO2008032858A3 Thiadiazole compound and use thereof |
| 07/24/2008 | WO2008029217A3 Dipeptidyl peptidase iv inhibitors |
| 07/24/2008 | WO2008024497A3 INHIBITORS OF 11β -HYDROXYSTEROID DEHYDROGENASE TYPE 1 |
| 07/24/2008 | WO2008022932A3 Controlled release system and method for manufacturing the same |
| 07/24/2008 | WO2008021375A3 Modulators of muscarinic receptors |
| 07/24/2008 | WO2008020939A3 Phenylalkyl n-hydroxyureas for combating atherosclerotic plaque |
| 07/24/2008 | WO2008020286A3 Pharmaceutical compositions of duloxetine |
| 07/24/2008 | WO2008020269A3 A method of treating tumors with azaxanthones |
| 07/24/2008 | WO2008016666A3 Certain chemical entities, compositions, and methods |
| 07/24/2008 | WO2008013710A3 Chewable tablet containing phenylephrine |
| 07/24/2008 | WO2008011609A3 Compositions and methods for vaccinating against hsv-2 |
| 07/24/2008 | WO2008011392A8 Proline urea ccr1 antagonists for the treatment of autoimmune diseases or inflammation |
| 07/24/2008 | WO2008009125A9 Tetrahydro-5h-pyrido[2,3-d]azepines as 5-ht2c ligands |